The statistical risk of intrastent stenosis has fallen considerably with the emergence of latest generation coated stents (drug-eluting stents: DES). The number and clinical lifespan of stents implanted over the last twenty-five years, however, explain the fact that restenosis remains a not unusual clinical problem which is expressed as a recurrence of angina or of an acute coronary syndrome (ACS). The mechanisms involved in this restenosis are multifactorial in nature and differ depending on the type of stent and the time since the restenosis occurred. In symptomatic stent restenosis (angina or acute coronary syndrome), a further angioplasty is usually required, occasionally on an emergency basis. Coronary angiography is often not capable of explaining the mechanical causes of this complication. Optical coherence tomography (OCT), a high-resolution endocoronary imaging technique can assist in the understanding of the mechanism of restenosis and guide treatment. OCT during angiography provides a detailed analysis of the stents and potential complications: the presence of neoatherosclerosis with or without plaque rupture, intimal hyperplasia, stent under-deployment, stent fracture and distal or proximal progression of the atherosclerosis. The investigators propose a prospective, multicentre study of all cases of intrastent restenosis, examined by angiography, causing clinical features involving stable angina and acute coronary syndrome. The coronary artery involved will be routinely studied by OCT for a mechanical cause of the intrastent restenosis. The routine use of intrastent OCT may assist in the understanding of causes of restenosis and in the decision on appropriate treatment. There are several possible treatments for restenosis, including balloon angioplasty, coated balloon angioplasty, stenting or aorto-coronary bypass graft surgery.
All stented coronary artery patients hospitalised for stable angina or an ACS requiring a further coronary angiogram (regardless of time since implantation or type of the initial stent) identified to have intrastent restenosis during coronary angiography will be included after being informed and obtaining their informed written consent. * For cases of stable angina the OCT the will be performed immediately with insertion of the probe distal to the area being studied and then automatic retraction of the fibre during injection of the contrast medium. * For ACS, the OCT will be performed immediately or on a deferred basis at the discretion of the operator. * For critical lesions which prevent the OCT fibre passing across the lesion, "soft" predilatation with a 2 mm or smaller balloon is permitted. * Practical conduct of the OCT: * Pullback at baseline state and analysis of the stent with a 5 mm margin proximal and distal to the lesion. * OCT analysis: under-deployment of the stent (expansion \< 80% of the reference mean surface area), neoatherosclerosis with or without rupture, homogeneous or non-homogeneous hyperplasia, stent fracture and proximal or distal progression of the atherosclerosis. * Final pullback in cases of a new angioplasty (balloon angioplasty, angioplasty with a coated balloon or stenting). * The OCT investigations will be anonymised and registered in their original format with a view to centralised reading (Corelab ISIT, UMR 6284-CNRS, Clermont-Ferrand University). * The angiography records will be submitted for reading by a panel blinded to the OCT for the purposes of demonstrating the added value of OCT in the fine details of diagnosis and the impact of a treatment decision. The angiograms will be reviewed in a centralised analytical laboratory, which will re-read the procedures blind. * Patients will be followed up via telephone contact or visit one year after inclusion into the study to record any complications which have developed (possible myocardial infarction, reason, any new revascularisation of the target lesion or another artery and reason for this, any deaths and their causes).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
307
The OCT fibre is an optical fibre catheter containing a lens located at its extremity and positioned distal to the arterial segment to be examined. This is an intracoronary, very high-resolution section technique based on absorption and reflection of close infrared light by stents and tissues. OCT analysis is performed during a usual coronary angiography procedure. It is a common technique already used and recommended for intrastent restenosis to establish the mechanism of the process. No new product is being tested. The examination performed is the same.
Université- Hôpital Leuven
Leuven, Belgium
CHU Clermont Ferrand
Clermont-Ferrand, Auvergne, France
Clinique la Roseraie
Aubervilliers, France
CH Avignon
Avignon, France
CHRU Besançon
Besançon, France
CHU Bordeaux
Bordeaux, France
CHRU Morvan
Brest, France
Hôpital privé saint Martin
Cauro, France
Centre Hospitalier les Hôpitaux de Chartres
Chartres, France
CHRU Grenoble Alpes
Grenoble, France
...and 17 more locations
Characteristics of morphological abnormalities, seen on OCT on millimetre sections of the whole stented segment (5 mm proximally and distally to the stent), potentially responsible for the intrastent restenosis
Under-deployment of the stent with percentage under-deployment is defined when the minimum intrastent surface area is less than 80% of the reference surface area.
Time frame: day 0
Characteristics of morphological abnormalities, seen on OCT on millimetre sections of the whole stented segment (5 mm proximally and distally to the stent), potentially responsible for the intrastent restenosis
Homogeneous or non-homogeneous intimal hyperplasia.
Time frame: day 0
Characteristics of morphological abnormalities, seen on OCT on millimetre sections of the whole stented segment (5 mm proximally and distally to the stent), potentially responsible for the intrastent restenosis
Presence of neoatherosclerosis, with or without rupture.
Time frame: day 0
Characteristics of morphological abnormalities, seen on OCT on millimetre sections of the whole stented segment (5 mm proximally and distally to the stent), potentially responsible for the intrastent restenosis
Stent fracture .
Time frame: day 0
Characteristics of morphological abnormalities, seen on OCT on millimetre sections of the whole stented segment (5 mm proximally and distally to the stent), potentially responsible for the intrastent restenosis
Progression of the proximal or distal atherosclerosis .
Time frame: day 0
Clinical data
time to onset of intrastent restenosis
Time frame: day 0
Clinical data
sex
Time frame: day 0
Clinical data
age
Time frame: day 0
Clinical data
past history of angioplasty
Time frame: day 0
Clinical data
myocardial infarction
Time frame: day 0
Clinical data
coronary artery bypass grafting
Time frame: day 0
Clinical data
multi-vessel disease
Time frame: day 0
Clinical data
prosthetic valve
Time frame: day 0
Clinical data
heart failure
Time frame: day 0
Clinical data
chronic renal failure
Time frame: day 0
Clinical data
atrial fibrillation
Time frame: day 0
Clinical data
valve disease
Time frame: day 0
Clinical data
vascular disease
Time frame: day 0
Clinical data
CVA
Time frame: day 0
Clinical data
TIA
Time frame: day 0
Cardiovascular risk factors
hypertension
Time frame: day 0
Cardiovascular risk factors
dyslipidaemia
Time frame: day 0
Cardiovascular risk factors
diabetes
Time frame: day 0
Cardiovascular risk factors
family history
Time frame: day 0
Cardiovascular risk factors
overweight (BMI \> 25)
Time frame: day 0
Cardiovascular risk factors
smoking habit
Time frame: day 0
Blood sample
Measure of LDL cholesterol
Time frame: day 0, day 365
Blood sample
Measure of HDL cholesterol
Time frame: day 0, day 365
Blood sample
Measure of triglycerides
Time frame: day 0, day 365
Blood sample
Measure of HbA1c
Time frame: day 0, day 365
Blood sample
Measure of creatinine
Time frame: day 0, day 365
Blood sample
Measure of renal clearance
Time frame: day 0, day 365
New revascularisation events
new revascularisation event in the target lesion or another artery, myocardial infarctions, deaths and causes of events
Time frame: day 365
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.